- Home
- RILYP vs SRPT Comparison
RILYP vs SRPT Comparison
Compare RILYP & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RILYP
- SRPT
- Stock Information
- Founded
- RILYP 1973
- SRPT 1980
- Country
- RILYP United States
- SRPT United States
- Employees
- RILYP 2383
- SRPT N/A
- Industry
- RILYP Investment Managers
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- RILYP Finance
- SRPT Health Care
- Exchange
- RILYP Nasdaq
- SRPT Nasdaq
- Market Cap
- RILYP N/A
- SRPT 2.0B
- IPO Year
- RILYP N/A
- SRPT 1997
- Fundamental
- Price
- RILYP $6.78
- SRPT $17.97
- Analyst Decision
- RILYP
- SRPT Hold
- Analyst Count
- RILYP 0
- SRPT 31
- Target Price
- RILYP N/A
- SRPT $40.61
- AVG Volume (30 Days)
- RILYP 38.1K
- SRPT 7.8M
- Earning Date
- RILYP 01-01-0001
- SRPT 11-05-2025
- Dividend Yield
- RILYP 7.03%
- SRPT N/A
- EPS Growth
- RILYP N/A
- SRPT N/A
- EPS
- RILYP N/A
- SRPT N/A
- Revenue
- RILYP $854,383,000.00
- SRPT $2,481,531,000.00
- Revenue This Year
- RILYP N/A
- SRPT $10.78
- Revenue Next Year
- RILYP N/A
- SRPT N/A
- P/E Ratio
- RILYP N/A
- SRPT N/A
- Revenue Growth
- RILYP N/A
- SRPT 64.89
- 52 Week Low
- RILYP $1.73
- SRPT $10.42
- 52 Week High
- RILYP $20.00
- SRPT $138.81
- Technical
- Relative Strength Index (RSI)
- RILYP 61.57
- SRPT 48.93
- Support Level
- RILYP $5.75
- SRPT $17.05
- Resistance Level
- RILYP $7.26
- SRPT $18.84
- Average True Range (ATR)
- RILYP 0.45
- SRPT 0.99
- MACD
- RILYP 0.05
- SRPT -0.04
- Stochastic Oscillator
- RILYP 67.88
- SRPT 43.30
About RILYP B. Riley Financial Inc.
B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.